当前位置: X-MOL 学术Cell cycle › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0/G1 arrest and apoptosis
Cell Cycle ( IF 3.4 ) Pub Date : 2020-12-14 , DOI: 10.1080/15384101.2020.1850969
Yanlin Song 1, 2 , Lu Li 1 , Jiao Chen 1 , Hongli Chen 1 , Bomiao Cui 1 , Yun Feng 1 , Ping Zhang 1 , Qiangsheng Zhang 1 , Yong Xia 3, 4 , Min Luo 1
Affiliation  

ABSTRACT

Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer and still lacks available targeted therapy options. Thioridazine hydrochloride (Thi-hyd), a common phenothiazine antipsychotic drug, has shown great tumor-suppressive potential in several types of cancer cells. In this study, we explored the anti-tumor effects of Thi-hyd on TNBC. Thi-hyd significantly inhibited the viability and migration of TNBC cells in vitro. PI3K/AKT signaling pathway was verified to be related to Thi-hyd-induced tumor inhibition. G0/G1 cell cycle arrest and apoptosis were observed after treatment with Thi-hyd. The cell cycle arrest was accompanied by down-regulation of CDK4/cyclin D1 and up-regulation of p21 and p27. The apoptosis was accompanied by mitochondrial dysfunction. In vivo, Thi-hyd significantly suppressed the growth of tumors showing a 63.73% inhibition rate in tumor weight. Spontaneous lung metastasis was also efficiently prevented by Thi-hyd treatment, with a 72.58% inhibition rate. Immunohistological analysis showed increased Ki67 expression and reduced cleaved caspase-3 expression in Thi-hyd-treated mice. No apparent side effects were observed according to blood test and H&E staining results. Collectively, our results show that Thi-hyd can be used as a potential drug for TNBC treatment and set the basis for its clinical evaluation and investigation.

Abbreviations

CCK8: Cell Counting Kit-8; CDK: cyclin-dependent kinase; DRD2: dopamine D2 receptor; ERK1/2: extracellular signal-regulated kinase 1/2; GAPDH: glyceraldehyde 3-phosphate dehydrogenase; H&E: hematoxylin and eosin; MMP: membrane potential; NAC: N-acetyl-L-cysteine; PI: Propidium iodide; Rh123: rhodamine-123; ROS: reactive oxygen species; TBST: tris-buffered saline containing 0.1% Tween 20 TNBC: Triple-negative breast cancer; Thi-hyd: Thioridazine hydrochloride.



中文翻译:

盐酸硫利达嗪:一种抗精神病药,通过诱导 G0/G1 期阻滞和细胞凋亡抑制三阴性乳腺癌的肿瘤生长和肺转移

摘要

三阴性乳腺癌 (TNBC) 是最具侵袭性的乳腺癌类型,仍然缺乏可用的靶向治疗方案。盐酸硫利达嗪 (Thi-hyd) 是一种常见的吩噻嗪类抗精神病药物,已在多种类型的癌细胞中显示出巨大的肿瘤抑制潜力。在这项研究中,我们探讨了三氢大麻酚对 TNBC 的抗肿瘤作用。Thi-hyd在体外显着抑制了 TNBC 细胞的活力和迁移。PI3K/AKT信号通路被证实与Thi-hyd诱导的肿瘤抑制有关。用 Thi-hyd 处理后观察到 G0/G1 细胞周期停滞和细胞凋亡。细胞周期停滞伴随着 CDK4/细胞周期蛋白 D1 的下调和 p21 和 p27 的上调。细胞凋亡伴随着线粒体功能障碍。体内, Thi-hyd 显着抑制了肿瘤的生长,显示出 63.73% 的肿瘤重量抑制率。Thi-hyd 治疗也有效地防止了自发性肺转移,抑制率为 72.58%。免疫组织学分析显示,在 Thi-hyd 处理的小鼠中,Ki67 表达增加,裂解的 caspase-3 表达减少。根据血液测试和 H&E 染色结果,没有观察到明显的副作用。总的来说,我们的结果表明 Thi-hyd 可用作 TNBC 治疗的潜在药物,并为其临床评估和研究奠定基础。

缩写

CCK8:细胞计数试剂盒-8;CDK:细胞周期蛋白依赖性激酶;DRD2:多巴胺D2受体;ERK1/2:细胞外信号调节激酶 1/2;GAPDH:3-磷酸甘油醛脱氢酶;H&E:苏木精和伊红;MMP:膜电位;NAC:N-乙酰基-L-半胱氨酸;PI:碘化丙啶;Rh123:罗丹明-123;ROS:活性氧;TBST:含有 0.1% Tween 20 TNBC 的 Tris 缓冲盐水:三阴性乳腺癌;Thi-hyd:盐酸硫利达嗪。

更新日期:2020-12-31
down
wechat
bug